Form 4 for RVMD Revolution Medicines, Inc.
Accepted 2022-07-13 00:00:00 ET · period of report 2022-07-12 · accession 0001567619-22-013970 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-07-13 | 2022-07-12 | RVMD | Kim Lorence H. | Dir | A - Grant | $0.00 | +10.5K | 10.5K | New | $0 |
| D | 2022-07-13 | 2022-07-12 | RVMD | Kim Lorence H. | Dir | A - Grant | $0.00 | +36.8K | 36.8K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-07-12 | A | A | 10,500 | $0.00 | 10,500 | D | — | — | (F1) Includes 10,500 Restricted Stock Units. |
| 2 | Derivative | Stock Option (Right to Buy) | 2022-07-12 | A | A | 36,800 | $0.00 | 36,800 | D | $22.48 · — to 2032-07-11 | 36,800 Common Stock | (F2) The option becomes exercisable as it vests and the shares subject to the option vest with respect to 1/36 of the shares subject thereto on each monthly anniversary of July 12, 2022, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date. |